Historique de carrière de Premal Patel
Anciens postes connus de Premal Patel
Sociétés | Poste | Début | Fin |
---|---|---|---|
EFFECTOR THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 25/08/2021 | 01/04/2022 |
LYELL IMMUNOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 01/07/2018 | 01/04/2020 |
JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/09/2017 | 01/04/2018 |
PFIZER, INC. | Corporate Officer/Principal | 01/08/2015 | 01/08/2017 |
Formation de Premal Patel
Rutgers State University of New Jersey | Undergraduate Degree |
University of Washington | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
EFFECTOR THERAPEUTICS, INC. | Health Technology |
LYELL IMMUNOPHARMA, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- Premal Patel
- Expérience